VFC
45
3
DRI
61
-2
KO
52
5
CSCO
53
2
GOOG
83
4
CRM
59
4
INTC
47
6
MAT
50
18
K
30
-2
MET
60
2
VLO
33
-5
HAL
41
11
HPE
46
-5
GWW
46
2
USB
37
4
JPM
60
-2
SWKS
57
-8
CME
33
-4
EW
40
2
SJM
29
-2
VFC
45
3
DRI
61
-2
KO
52
5
CSCO
53
2
GOOG
83
4
CRM
59
4
INTC
47
6
MAT
50
18
K
30
-2
MET
60
2
VLO
33
-5
HAL
41
11
HPE
46
-5
GWW
46
2
USB
37
4
JPM
60
-2
SWKS
57
-8
CME
33
-4
EW
40
2
SJM
29
-2
Financhill
Back

Paycom Software Vs. Ultragenyx Pharmaceutical Industry Stock Comparison

Sell
28

PAYC
Paycom Software

Last Price:
147.32
Seasonality Move:
12.92%
Sell
43

RARE
Ultragenyx Pharmaceutical

Last Price:
39.58
Seasonality Move:
3.65%
Sell
28
Paycom Software (PAYC) is a Sell

Is Paycom Software a Buy, Sell or Hold?

  • The current Paycom Software [PAYC] share price is $147.40. The Score for PAYC is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
  • PAYC is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
43
Ultragenyx Pharmaceutical (RARE) is a Sell

Is Ultragenyx Pharmaceutical a Buy, Sell or Hold?

  • The current Ultragenyx Pharmaceutical [RARE] share price is $39.60. The Score for RARE is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
  • RARE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

PAYC Stock Price Chart

What is Paycom Software's stock price today?

  • The Paycom Software share price today is $147.40
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PAYC is experiencing buying pressure, which is a positive indicator for future bullish movement.

RARE Stock Price Chart

What is Ultragenyx Pharmaceutical's stock price today?

  • The Ultragenyx Pharmaceutical share price today is $39.60
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RARE is experiencing buying pressure, which is a positive indicator for future bullish movement.

PAYC Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -7.95 Sell
Relative Strength Index (14 RSI): 38.05 Sell
Chaikin Money Flow: 2506936 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (140.91 - 171.53) Sell
Bollinger Bands (100): (162.65 - 197.59) Sell

RARE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.73 Sell
Relative Strength Index (14 RSI): 45.77 Sell
Chaikin Money Flow: 722527 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (38.99 - 42.29) Sell
Bollinger Bands (100): (41.03 - 48.83) Sell

PAYC Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 143.59 Buy
20-day SMA: 150.08 Sell
50-day SMA: 169.71 Sell
200-day SMA: 199.88 Sell
8-day EMA: 145.03 Buy
20-day EMA: 151.11 Sell
50-day EMA: 164.78 Sell
200-day EMA: 202.62 Sell

RARE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 40.38 Sell
20-day SMA: 40.41 Sell
50-day SMA: 41.94 Sell
200-day SMA: 42.46 Sell
8-day EMA: 39.76 Sell
20-day EMA: 40.54 Sell
50-day EMA: 42.03 Sell
200-day EMA: 43.46 Sell

Paycom Software Earnings Growth & PAYC Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.08 per share, an increase next quarter of $0.21 per share, an increase this year of $0.16 per share, and an increase next year of $1.08 per share.

Ultragenyx Pharmaceutical Earnings Growth & RARE Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.49 per share, an increase next quarter of $0.01 per share, an increase this year of $0.90 per share, and an increase next year of $1.07 per share.

Paycom Software Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Ultragenyx Pharmaceutical Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):